Equities

BlackRock Health Sciences Trust

BME:NYQ

BlackRock Health Sciences Trust

Actions
FinancialsClosed End Investments
  • Price (USD)40.08
  • Today's Change-0.29 / -0.72%
  • Shares traded29.37k
  • 1 Year change-0.67%
  • Beta0.6822
Data delayed at least 15 minutes, as of May 24 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, approximately 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust is focused on achieving its goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include biotechnology, health care equipment and supplies, life sciences tools and services, and pharmaceuticals. BlackRock Advisors, LLC acts as the manager of the Trust.

  • Revenue in USD (TTM)8.19m
  • Net income in USD20.02m
  • Incorporated2005
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Invesco Value Municipal Income Trust44.60m46.32m543.17m--11.730.8506--12.180.98420.98420.947513.570.0461--15.42--4.781.054.841.0655.8666.43103.8825.96----0.3261260.15-2.10-2.51152.7310.07---5.85
Pimco Municipal Income Fund II-100.00bn-100.00bn552.59m0.00------------------------------------------------------------
BlackRock Enhanced Interntnl Dvdnd Trust-100.00bn-100.00bn555.54m--------------------------------------------------------------
India Fund Inc5.45m97.86m556.84m--5.651.00--102.193.173.170.177417.870.0099--31.49--17.765.8118.386.04-10.46-4.401,795.94566.60----0.00172.62-0.1874-9.51192.07-----10.15
Nuveen Calfrna AMT-Free Qlty Mncpl IncFd-100.00bn-100.00bn557.41m--------------------------------------------------------------
Blackrock Health Sciences Trust8.19m20.02m562.92m--28.120.9571--68.701.441.440.587642.180.0136--4.11--3.337.743.347.8048.04--244.30652.44----0.000172.215.9812.56175.62-2.26--1.30
John Hancock Financial Opprts Fund-100.00bn-100.00bn563.63m--------------------------------------------------------------
Western Asset Emerging Mrkts Dbt Fnd Inc65.72m71.40m563.64m--7.650.89817.898.581.241.241.1210.570.076--667.47--8.261.238.291.2966.0875.47108.6519.26----0.2882459.358.04-5.61147.73-----5.18
Acacia Research Corp134.62m47.76m566.12m170.00148.520.99628.154.210.03810.03811.285.680.22661.7011.20791,876.509.988.2211.4010.3384.5080.0144.0563.9621.02--0.0216--111.24-0.9935141.45--183.16--
Clearbridge Energy MidstreamOprtntyFdInc11.94m64.95m569.69m--8.401.10--47.715.085.080.933838.750.0173--17.23--9.38-1.239.40-1.23-62.75-96.09543.95-98.84----0.3044--50.9325.10-55.63-----18.02
Eaton Vance Risk-Mngd Dvrsfd Eqty Inc Fd7.73m80.35m572.25m0.007.141.01--74.021.191.190.11498.490.0138--9.92--14.368.0014.508.0924.1635.201,039.36502.77----0.00105.09-12.89-6.19179.64-----8.17
Blackrock Multi-Sector Income Trust-100.00bn-100.00bn573.43m----1.03----------14.76----------------------------0.3424--------------
Cohen & Steers Ltd DrtnPrfrrd&IncmFndInc56.42m38.94m574.02m--14.740.9615--10.171.341.341.9420.530.0612--4.20--4.223.576.475.2054.6469.9469.0166.19----0.3454143.407.39-0.0834145.62-----3.12
Nuveen Municipal Credit Opprtntes Fund56.06m-25.71m574.32m----1.04--10.24-0.4691-0.46911.0210.060.0514--2.99---2.36---2.46--45.62---45.86----0.49690.4489---9.84--86.71------
BlackRock Core Bond Trust52.03m55.26m576.83m--10.440.9695--11.091.021.020.963311.020.0525--2.79--5.57--9.31--59.60--106.22------0.336--8.95--127.20------
John Hancock Premium Dividend Fund-100.00bn-100.00bn576.94m--------------------------------------------------------------
Data as of May 24 2024. Currency figures normalised to BlackRock Health Sciences Trust's reporting currency: US Dollar USD

Institutional shareholders

17.26%Per cent of shares held by top holders
HolderShares% Held
Wells Fargo Clearing Services LLCas of 31 Mar 2024401.46k3.20%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024384.42k3.06%
Nova R Wealth, Inc.as of 31 Mar 2024357.87k2.85%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024181.30k1.44%
Columbia Management Investment Advisers LLCas of 31 Mar 2024177.39k1.41%
UBS Financial Services, Inc.as of 31 Mar 2024143.23k1.14%
Cornerstone Advisory LLC /Maryland/as of 31 Mar 2024139.02k1.11%
RBC Capital Markets LLC (Investment Management)as of 31 Mar 2024134.01k1.07%
Invesco Capital Management LLCas of 31 Mar 2024126.99k1.01%
1607 Capital Partners LLCas of 31 Mar 2024123.48k0.98%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.